Nath Bio-Genes (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/07/2025 ,inter alia, to consider and approve unaudited financial ....
NATHBIOGEN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Nath Bio-Genes (India) Ltd has informed BSE that its Board of Directors will meet on 11/07/2025 to consider and approve the unaudited financial results for the period ended 30/06/2025 (likely Q1 FY26). The full agenda of the board meeting and any other matters to be discussed were not detailed in this intimation. This is a standard regulatory disclosure required before announcing quarterly results. No financial figures or performance metrics are disclosed in this filing.
This is a routine compliance announcement and does not directly impact the stock price. Investors should watch for the actual unaudited results announcement, which typically follows within 24-48 hours after the board meeting, as it will reveal the company's quarterly performance.